Does roflumilast induce phagocytic activity in COPD patients?

被引：0
|
作者：
Ghosh, Baishakhi [1 ,2 ]
Vanjare, Nitin V. [1 ]
机构：
[1] Chest Res Fdn, Pune 411014, Maharashtra, India
[2] Symbiosis Int Univ, Fac Hlth & Biomed Sci, Pune, Maharashtra, India
来源：
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015年 / 10卷
关键词：
OBSTRUCTIVE PULMONARY-DISEASE;
D O I：
10.2147/COPD.S92812
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effect of roflumilast in patients with severe COPD and a history of hospitalisation
    Rabe, Klaus F.
    Calverley, Peter M. A.
    Martinez, Fernando J.
    Fabbri, Leonardo M.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (01)
  • [22] Inflammation in COPD patients before and after roflumilast treatment
    Vargas-Rojas, Maria Ines
    Solleriro-Villavicencio, Helena
    Ramirez-Venegas, Alejandra
    Hernandez-Zenteno, Rafael
    Perez-Bautista, Oliver
    Ziga-Martinez, Abraham
    Quintana-Carrillo, Roger
    Duenas-Morales, Fernando
    Sansores-Martinez, Rasul
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [23] Cardiovascular Safety in Patients Receiving Roflumilast for the Treatment of COPD
    White, William B.
    Cooke, Glen E.
    Kowey, Peter R.
    Calverley, Peter M. A.
    Bredenbroeker, Dirk
    Goehring, Udo-Michael
    Zhu, Haiyuan
    Lakkis, Hassan
    Mosberg, Hans
    Rowe, Paul
    Rabe, Klaus F.
    CHEST, 2013, 144 (03) : 758 - 765
  • [24] Neutrophils and spirometry changes in COPD patients treated with roflumilast
    Domvri, Kalliopi
    Porpodis, Konstantinos
    Papaioannou, Antonis
    Zarogoulidis, Paul
    Petridis, Dimitrios Dimitrios
    Hatzizisi, Olga
    Liaka, Alexandra
    Kikidaki, Violeta
    Lampaki, Sofia
    Organtzis, Ioannis
    Zarogoulidis, Konstantinos
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [25] Characteristics Of COPD Patients Treated With Roflumilast During Hospitalization
    Sun, S. X.
    Huang, X.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [26] Risk of cardiovascular events among COPD patients using roflumilast
    Lee, Inyoung
    Zueger, Patrick M.
    Lee, Todd A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 286 - 287
  • [27] COPD Patients Initiating Roflumilast in Sweden, Germany and the United States: Findings from the Roflumilast PASS Study
    Hoti, Fabian
    Mushnikov, Vasili
    Mehtala, Juha
    Wentzell, Nadine
    Kollhorst, Bianca
    Schink, Tania
    Garbe, Edeltraut
    Mountford, William K.
    Knox, Caitlin
    Kaufman, Elise
    Johansson, Gunnar
    Korhonen, Pasi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 679 - 679
  • [28] Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol
    Calverley, Peter M. A.
    Martinez, Fernando J.
    Fabbri, Leonardo M.
    Goehring, Udo-Michael
    Rabe, Klaus F.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 7 : 375 - 382
  • [29] Effects of Roflumilast on Rehospitalization and Mortality in Patients Hospitalized with a COPD Exacerbation
    Criner, Gerard J.
    Jacobs, Michael R.
    Zhao, Huaqing
    Marchetti, Nathaniel
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2019, 6 (01): : 74 - 85
  • [30] Roflumilast in COPD: a Brazilian perspective
    Stirbulov, Roberto
    Jardim, Jose R.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1853 - 1855
12345